bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
ABSTRACT
Obesity,
insulin
resistance,
and
a
host
of
environmental
genetic
factors
can
drive
hyperglycemia,
causing
β-cells
to
compensate
by
increasing
production
secretion.
In
type
2
diabetes
(T2D),
under
these
conditions
eventually
fail.
Rare
β-cell
diseases
like
congenital
hyperinsulinism
(HI)
also
cause
inappropriate
secretion,
some
HI
patients
develop
diabetes.
However,
the
mechanisms
hypersecretion
how
it
causes
dysfunction
are
not
fully
understood.
We
previously
discovered
small
molecules
(e.g.
SW016789)
that
lead
loss
in
function
without
cell
death.
Here,
we
uncover
protein
target
SW016789
provide
first
time-course
transcriptomic
analysis
hypersecretory
responses
versus
thapsigargin-mediated
ER
stress
β-cells.
mouse
MIN6
human
EndoC-βH1
β-cells,
identified
validated
VDAC1
as
using
photoaffinity
proteomics,
cellular
thermal
shift
assays,
siRNA,
molecule
inhibitors.
raises
membrane
potential
enhance
Ca
2+
influx,
potentially
through
VDAC1.
Chronically
elevated
intracellular
appears
underpin
negative
impacts
hypersecretion,
nifedipine
protected
against
each
inducer
tested.
Using
time-
course
RNAseq,
induced
distinct
transcriptional
pattern
compared
stress.
Clustering
analyses
led
us
focus
on
ER-associated
degradation
(ERAD)
mediator
adaptive
response.
reduced
abundance
ERAD
substrate
OS-9
pharmacological
inhibition
worsened
survival
response
Changes
other
components
at
level
were
minor
with
either
or
thapsigargin.
immunostaining
for
core
SEL1L,
HRD1,
DERL3
non-diabetic
T2D
pancreas
revealed
altered
distributions
SEL1L/HRD1
SEL1L/DERL3
rations
islets,
alignment
stressed
conclude
stimuli,
including
SW016789-
mediated
activation,
enhanced
influx
release.
Subsequent
differential
gene
expression
represents
signature
is
reflected
some,
but
all
genes.
A
better
understanding
induce
feedback
secretory
rate
may
discovery
novel
therapeutic
targets
HI.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 22, 2025
Pancreatic
islets
maintain
glucose
homeostasis
through
coordinated
action
of
their
constituent
endocrine
and
affiliate
cell
types
are
central
to
type
2
diabetes
(T2D)
genetics
pathophysiology.
Our
understanding
robust
human
islet
type-specific
alterations
in
T2D
remains
limited.
Here,
we
report
comprehensive
single
transcriptome
profiling
245,878
cells
from
a
48-donor
cohort
spanning
non-diabetic
(ND),
pre-diabetic
(PD),
states,
identifying
14
distinct
detected
every
donor
each
glycemic
state.
Cohort
analysis
reveals
∼25-30%
loss
functional
beta
mass
vs.
ND
or
PD
donors
resulting
(1)
reduced
total
numbers/proportions
(2)
reciprocal
'high
function'
gain
senescent
β-cell
subpopulations.
We
identify
β-cells
511
differentially
expressed
genes
(DEGs),
including
new
(66.5%)
validated
(e.g.,
FXYD2,
SLC2A2,
SYT1
),
significant
neuronal
transmission
vitamin
A
metabolism
pathway
alterations.
Importantly,
demonstrate
newly
identified
DEG
roles
viability
and/or
insulin
secretion
link
47
DEGs
diabetes-relevant
phenotypes
knockout
mice,
implicating
them
as
potential
causal
dysfunction
genes.
Additionally,
nominate
candidate
therapeutic
targets
27
for
which
genetic
risk
variants
(GWAS
SNPs)
pathophysiology
(T2D
ND)
exert
concordant
expression
effects.
provide
this
freely
accessible
atlas
data
exploration,
analysis,
hypothesis
testing.
Together,
study
provides
genomic
resources
insights
into
dysfunction.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 20, 2025
Diabetes
mellitus
(DM)
is
a
global
health
crisis
affecting
millions,
with
islet
transplantation
emerging
as
promising
treatment
strategy
to
restore
insulin
production.
This
review
synthesizes
the
current
research
on
single-cell
and
spatial
transcriptomics
in
context
of
transplantation,
highlighting
their
potential
revolutionize
DM
management.
Single-cell
RNA
sequencing,
offers
detailed
look
into
diversity
functionality
within
grafts,
identifying
specific
cell
types
states
that
influence
graft
acceptance
function.
Spatial
complements
this
by
mapping
gene
expression
tissue's
context,
crucial
for
understanding
microenvironment
surrounding
transplanted
islets
interactions
host
tissues.
The
integration
these
technologies
comprehensive
view
cellular
microenvironments,
elucidating
mechanisms
underlying
function,
survival,
rejection.
instrumental
developing
targeted
therapies
enhance
performance
patient
outcomes.
emphasizes
significance
avenues
informing
clinical
practices
improving
outcomes
patients
through
more
effective
strategies.
Future
directions
include
application
personalized
medicine,
developmental
biology,
regenerative
predict
disease
progression
responses.
Addressing
ethical
technical
challenges
will
be
successful
implementation
integrated
approaches
practice,
ultimately
enhancing
our
ability
manage
improve
quality
life.
PeerJ,
Journal Year:
2025,
Volume and Issue:
13, P. e19192 - e19192
Published: March 28, 2025
Type
2
diabetes
mellitus
(T2DM)
is
a
globally
prevalent
metabolic
disorder
characterized
by
insulin
resistance
and
dysfunction
of
islet
cells.
Endoplasmic
reticulum
(ER)
stress
plays
crucial
role
in
the
pathogenesis
progression
T2DM,
especially
function
survival
β-cells.
β-cells
are
particularly
sensitive
to
ER
because
they
require
substantial
synthesis
secretion
energy.
In
early
stages
increased
demand
for
exacerbates
β-cell
stress.
Although
unfolded
protein
response
(UPR)
can
temporarily
alleviate
this
stress,
prolonged
or
excessive
leads
pancreatic
cell
apoptosis,
resulting
insufficient
secretion.
This
review
explores
mechanisms
its
impact
on
We
discuss
how
activates
UPR
signaling
pathways
regulate
folding
degradation,
but
when
becomes
excessive,
these
may
contribute
death.
A
deeper
understanding
impacts
cells
could
lead
development
novel
T2DM
treatment
strategies
aimed
at
improving
slowing
disease
progression.
Stem Cells Translational Medicine,
Journal Year:
2024,
Volume and Issue:
13(10), P. 949 - 958
Published: Aug. 19, 2024
Abstract
Stem
cell-derived
islets
(SC-islets)
offer
the
potential
to
be
an
unlimited
source
of
cells
for
disease
modeling
and
treatment
diabetes.
SC-islets
can
genetically
modified,
treated
with
chemical
compounds,
or
differentiated
from
patient
derived
stem
model
These
models
provide
insights
into
pathogenesis
vulnerabilities
that
may
targeted
treatment.
themselves
are
also
being
investigated
as
a
cell
therapy
However,
transplantation
process
is
imperfect;
side
effects
immunosuppressant
use
have
reduced
SC-islet
therapeutic
potential.
Alternative
methods
this
include
encapsulation,
immunomodulating
molecules,
genetic
modification
SC-islets.
This
review
covers
recent
advances
using
understand
different
diabetes
pathologies
therapy.
Journal of Diabetes,
Journal Year:
2024,
Volume and Issue:
16(11)
Published: Nov. 1, 2024
Diabetes
mellitus
(DM)
is
a
chronic
metabolic
disorder
that
occurs
when
pancreatic
β-cells
can
no
longer
produce
enough
insulin
to
maintain
normal
blood
glucose
levels.
DM
presently
affects
10.5%
of
the
world
adult
population.
While
T1D
disease
"mistaken
identity,"
where
immune
system
attacks
and
destroys
in
context
islet
inflammation
(insulitis),1
T2D
associated
with
sedentary
lifestyles
high-fat
diets,
typically
involving
ineffective
use
progressive
loss
β-cell
function.1
Both
diseases
result
from
multifaceted
interactions
between
genetic
environmental
factors,
failure
as
core
mechanism
pathogenesis.
In
T1D,
arises
complex
interaction
cells
β-cells,
chemokine
cytokine
release
signals
stressed
or
dying
attract
activate
islets
lead
apoptosis.2
Beyond
destruction
by
system,
it
now
accepted
stress
impaired
function
these
significantly
contribute
onset
progression
disease.1-3
T2D,
driven
an
interplay
resistance
dysfunction
genetically
susceptible
individuals,
perhaps
also
impairing
secretion
eventually
survival,
although
less
degree
than
T1D.1,
4,
5
The
complexity
diabetes
pathogenesis
makes
very
difficult
identify
specific
causes
disease,
which
hampers
development
adequate
therapies
protect
thus
prevent
disease.
This
difficulty
was
well
described
Tolstoy,
his
masterpiece
"War
Peace,"
published
1869
(in
this
case
addressing
Napoleonic
war
against
tsarist
Russia):
"…the
impulse
seek
innate
soul
man.
And
human
intellect,
inkling
on
immense
variety
circumstances
conditioning
phenomena,
any
one
may
be
separately
conceived
cause
it,
snatches
first
most
easily
understood
approximation,
says
here
cause."
pathophysiology,
had
led
simplistic
view
"one
gene,
protein,
disease."
However,
sequencing
genome
subsequent
advent
omics
technologies
allow
interrogating
whole
parallel
often
sequential
way,
our
understanding
changed:
we
focus
gene
transcription
factor
networks
post-transcriptional
post-translational
mechanisms.
single-cell
RNA
(scRNA-seq)
has
provided
new
tool
for
dissecting
molecular
intricacies
underlying
mechanisms
closer
its
real
"immense
circumstances."
A
recent
study
Maestas
et
al.
focused
utilizing
vitro
models
investigate
effects
ER
inducers
(thapsigargin,
brefeldin
A)
inflammatory
cytokines
(IFNγ,
IL1β,
TNFα,
their
combination)
using
five
donors
scRNA-seq
analysis.6
interesting
information,
but
limited
number
conditions
model
have
not
fully
captured
vivo
context.
To
further
signatures
potentially
present
analyzed
data
Human
Pancreas
Analysis
Program
(HPAP).7,
8
HPAP
provides
extensive
public
database
non-diabetic
individuals
affected
offering
valuable
resource
disease-specific
transcriptional
profiles
β-cells.
We
re-analyzed
up
12.2023,
includes
10X
Genomics
27
non-diabetic,
7
10
previously
pipeline.9
employed
indexed
signature
scoring
method,9-11
profile
six
sets
signatures,
namely,
inflammation,
senescence,
autophagy,
apoptosis,
endoplasmic
reticulum
(ER)
protein
processing,
unfolded
response
(UPR).
collected
previous
study,
comprises
80
genes
highly
stimulated
(i.e.,
>3
fold)
IFN-α,
IFN-γ,
IL-1β
insulin-producing
EndoC-βH1
cells.9
remaining
are
derived
Reactome
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
databases
included
following
genes:
157
cellular
senescence;
146
autophagy;
140
apoptosis;
170
processing;
92
UPR.
potential
limitation
analysis
diverse
recovered
three
groups
(15
281
controls,
585
1455
T2D),
due
both
different
inherent
course
(associated
isolating
diabetes).
spite
methodological
limitation,
revealed
all
were
upregulated
showing
higher
scores
forms
(Figure
1).
Notably,
exhibited
>200%
increase
score
compared
controls.
There
clear
apoptosis
(20%–43%),
only
mild
(6%–27%)
These
results
confirm
extend
observations
al.6
experience
multiple
stress,
while
emphasizing
undergo
more
severe
line
faster
massive
T2D.5
Proper
processing
under
necessitates
physiological
transient
activation
UPR,
prolonged
excessive
("terminal"
UPR)
trigger
cell
death.5
understand
relationship
UPR
senescence
diabetes,
conducted
correlation
above
index
scores.
significant
positive
2),
strongest
observed
2A),
detection
histology
markers
T1D.12
causality
developed
regression
formulations:
~
+
autophagy
found
signaling
pathways
together
effectively
predict
death
(R2
=
0.80)
0.75).
implications
ours
findings
twofold.
First,
targeting
pathways—particularly
senescence—may
offer
therapeutic
strategy
and,
extent,
T2D.
observations,
however,
must
considered
caution
instance
alone
sufficient
many
secretory
phenotype
downstream
factors
NF-κB
STATs,13
part
autoimmune-induced
insulitis,2,
making
discriminate
senescence-
inflammation-induced
T1D.
support
role
components
contributing
demonstration
targeted
elimination
senescent
non-obese
(NOD)
diabetic
mice,14
fact
early
residual
patients
T1D.15
indicated
Excessive
and/or
contributes
promoting
resistance.16
IRE1,
UPR's
master
regulators,
induces
degeneration
at
"terminal"
level,
inhibition
IRE1
mouse
protects
provide
opportunities
diabetes.17
Moreover,
another
regulator,
namely
eIF2α
kinase
PERK,
reverses
translation
blockade
prevents
NOD
mice.18
Of
interest,
there
crosstalk
stresses,
deletion
ATF6
IRE1α
mice
before
insulitis
leads
p21-driven
paradoxically
reduces
terminal
incidence
diabetes.15
Future
research
should
explore
leading-edge
discussed
above,
combined
impact
survival
across
types
diabetes.
comment
highlights
method
based
44
donors.
Key
indicate
(and
extent
T2D)
characterized
elevated
disturbances
pathways.
Strong
correlations
senescence.
add
relevant
information
emphasize
relevance
studying
tissues
autoimmune
degenerative
search
better
address
level
complexity.10,
19
Decio
L.
Eizirik
conceptualized
Xiaoyan
Yi
performed
drafted
manuscript.
contributed
reviewing,
editing,
adding
content.
authors
approved
final
version
keeping
latest
guidelines
International
Committee
Medical
Journal
Editors.
serve
guarantors
work.
grateful
Database
Consortium
publicly
available.
Research
supported
grants
Breakthrough
(formerly
JDRF
(3-SRA-2022-1201-S-B
[1]
3-SRA-2022-1201-S-B
[2]));
National
Institutes
Health
-
Islet
Network
Beta
Cell
Death
&
Survival
Pancreatic
β-Cell
Gene
Networks
Therapy
(HIRN-CBDS)
(grant
U01
DK127786);
NIDDK
grants,
RO1DK126444
RO1DK133881-01.
declare
conflicts
interest
related
commentary.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
Pancreatic
endocrine-exocrine
crosstalk
plays
a
key
role
in
normal
physiology
and
disease.
For
instance,
endocrine
islet
beta
(β)
cell
secretion
of
insulin
or
cholecystokinin
(CCK)
promotes
progression
pancreatic
adenocarcinoma
(PDAC),
an
exocrine
cell-derived
tumor.
However,
the
cellular
molecular
mechanisms
that
govern
signaling
tumorigenesis
remain
incompletely
understood.
We
find
β
ablation
impedes
PDAC
development
mice,
arguing
pancreas
is
critical
for
tumorigenesis.
Conversely,
obesity
induces
hormone
dysregulation,
alters
CCK-dependent
peri-islet
transcriptional
states,
enhances
proximal
tumor
formation.
Single-cell
RNA-sequencing,
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 24, 2024
Coxsackievirus
B
(CVB)
infection
has
long
been
considered
an
environmental
factor
precipitating
Type
1
diabetes
(T1D),
autoimmune
disease
marked
by
loss
of
insulin-producing
β
cells
within
pancreatic
islets.
Previous
studies
have
shown
CVB
negatively
impacts
islet
function
and
viability
but
do
not
report
on
how
virus
individually
affects
the
multiple
cell
types
present
in
human
primary
Therefore,
we
hypothesized
that
various
populations
unique
transcriptional
responses
to
infection.
Here,
performed
single-cell
RNA
sequencing
cadaveric
islets
treated
with
either
or
poly(I:C),
a
viral
mimic,
for
24
48
hours.
Our
global
analysis
reveals
differentially
induces
dynamic
changes
associated
processes
functions
over
time
whereas
poly(I:C)
promotes
immune
response
progressively
increases
treatment
duration.
At
resolution,
find
infects
all
at
similar
rates
yet
cell-type
specific
β,
α,
ductal
having
strongest
response.
Sequencing
functional
data
suggest
mitochondrial
respiration
morphology
distinct
ways
α
cells,
while
also
promoting
generation
reactive
oxygen
species.
We
observe
increase
expression
long-noncoding
Frontiers in Marine Science,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 13, 2024
Diabetes
mellitus
(DM),
a
major
global
health
concern,
is
chronic
metabolic
disorder.
Bioactive
compounds
sourced
from
numerous
marine
natural
products
recently
have
drawn
attention
as
novel
therapeutic
approaches.
Considering
these
chemicals
and
their
role
in
cellular
redox
modulation
by
involving
the
nuclear
factor
erythroid
2-related
2
(Nrf2)/heme
oxygenase
1
(HO-1)
pathway,
current
study
attempts
to
highlight
anti-diabetic
effects
molecular
mechanisms
involved.
Reactive
oxygen
species
(ROS)-mediated
oxidative
stress,
inflammation,
damage
are
linked
most
human
pathologies
specifically
DM.
The
Nrf2/HO-1
pathway
key
defense
mechanism
developed
cells
combat
ROS
burst.
Marine
strong
pharmacological
potential
triggering
antioxidant
declining
inflammation
How
potentially
alleviate
DM
type
diabetes
(T2D)
its
related
issues
especially
focused
on.
literature
was
thoroughly
analyzed
open
discussion
about
specific
well-established
elucidate
possible
applications.
Furthermore,
opportunities
pros
cons
of
using
bioactive
complementary
treatment
for
also
discussed.
diverse
characteristics
products,
with
regard
control,
offer
promising
drug
discovery
interventions
clinical
trials.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 24, 2024
Type
1
diabetic
human
islet
β-cells
are
deficient
in
double
C
2
like
domain
beta
(DOC2b)
protein.
Further,
DOC2b
protects
against
cytokine-induced
pancreatic
β-cell
stress
and
apoptosis.
However,
the
mechanisms
underpinning
protective
effects
of
remain
unknown.
Biochemical
studies,
qPCR,
proteomics,
immuno-confocal
microscopy
were
conducted
to
determine
underlying
β-cells.
DOC2b-
enriched
or-depleted
primary
islets
(human
mouse)
lines
challenged
with
or
without
proinflammatory
cytokines,
global
heterozygous
knockout
mice
subjected
multiple-low-dose-streptozotocin
(MLD-STZ),
used
for
these
studies.
A
significant
elevation
stress-induced
CXCL10
mRNA
was
observed
depleted
mouse
islets.
enrichment
markedly
attenuated
levels
non-diabetic
also
reduced
total-NF-κB
p65
protein
T1D
mimicking
cytokines.
IKKβ,
NF-κB
p65,
STAT-1
capable
associating
cytokine-challenged
cytokine-stressed
corresponded
a
reduction
activated
total
IKKβ
levels.
Total
IκBβ
increased
DOC2b-enriched
acute
cytokine
challenge.
Cytokine-induced
Intriguingly,
prevents
ER-stress-IKKβ
crosstalk
rat
INS1-832/13
line.
The
involve
attenuation
IKKβ-NF-κB
signaling,
expression.